CA2531917A1 - Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides - Google Patents
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides Download PDFInfo
- Publication number
- CA2531917A1 CA2531917A1 CA002531917A CA2531917A CA2531917A1 CA 2531917 A1 CA2531917 A1 CA 2531917A1 CA 002531917 A CA002531917 A CA 002531917A CA 2531917 A CA2531917 A CA 2531917A CA 2531917 A1 CA2531917 A1 CA 2531917A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- acid sequence
- shows
- sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (80)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US00/05601 | 2000-03-01 | ||
| PCT/US2000/005601 WO2000056889A2 (fr) | 1999-03-23 | 2000-03-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
| PCT/US2000/005841 WO2000053758A2 (fr) | 1999-03-08 | 2000-03-02 | Compositions et methodes de traitement des maladies immunitaires |
| USPCT/US00/05841 | 2000-03-02 | ||
| US18720200P | 2000-03-03 | 2000-03-03 | |
| US60/187,202 | 2000-03-03 | ||
| US18696800P | 2000-03-06 | 2000-03-06 | |
| US60/186,968 | 2000-03-06 | ||
| US18932800P | 2000-03-14 | 2000-03-14 | |
| US18932000P | 2000-03-14 | 2000-03-14 | |
| US60/189,320 | 2000-03-14 | ||
| US60/189,328 | 2000-03-14 | ||
| PCT/US2000/006884 WO2001005972A1 (fr) | 1999-07-20 | 2000-03-15 | Compositions et methodes pour traiter des maladies d'ordre immunologique |
| USPCT/US00/06884 | 2000-03-15 | ||
| US19082800P | 2000-03-21 | 2000-03-21 | |
| US19100700P | 2000-03-21 | 2000-03-21 | |
| US19104800P | 2000-03-21 | 2000-03-21 | |
| US19131400P | 2000-03-21 | 2000-03-21 | |
| US60/191,314 | 2000-03-21 | ||
| US60/190,828 | 2000-03-21 | ||
| US60/191,007 | 2000-03-21 | ||
| US60/191,048 | 2000-03-21 | ||
| US19265500P | 2000-03-28 | 2000-03-28 | |
| US60/192,655 | 2000-03-28 | ||
| US19305300P | 2000-03-29 | 2000-03-29 | |
| US19303200P | 2000-03-29 | 2000-03-29 | |
| US60/193,053 | 2000-03-29 | ||
| US60/193,032 | 2000-03-29 | ||
| USPCT/US00/08439 | 2000-03-30 | ||
| PCT/US2000/008439 WO2000073454A1 (fr) | 1999-06-02 | 2000-03-30 | Polypeptides transmembranaires secretes et acides nucleiques codants pour ceux-ci |
| US19444900P | 2000-04-04 | 2000-04-04 | |
| US19464700P | 2000-04-04 | 2000-04-04 | |
| US60/194,647 | 2000-04-04 | ||
| US60/194,449 | 2000-04-04 | ||
| US19682000P | 2000-04-11 | 2000-04-11 | |
| US19600000P | 2000-04-11 | 2000-04-11 | |
| US19597500P | 2000-04-11 | 2000-04-11 | |
| US19618700P | 2000-04-11 | 2000-04-11 | |
| US19669000P | 2000-04-11 | 2000-04-11 | |
| US60/195,975 | 2000-04-11 | ||
| US60/196,690 | 2000-04-11 | ||
| US60/196,187 | 2000-04-11 | ||
| US60/196,000 | 2000-04-11 | ||
| US60/196,820 | 2000-04-11 | ||
| US19812100P | 2000-04-18 | 2000-04-18 | |
| US19858500P | 2000-04-18 | 2000-04-18 | |
| US60/198,585 | 2000-04-18 | ||
| US60/198,121 | 2000-04-18 | ||
| US19939700P | 2000-04-25 | 2000-04-25 | |
| US19955000P | 2000-04-25 | 2000-04-25 | |
| US19965400P | 2000-04-25 | 2000-04-25 | |
| US60/199,397 | 2000-04-25 | ||
| US60/199,654 | 2000-04-25 | ||
| US60/199,550 | 2000-04-25 | ||
| US20151600P | 2000-05-03 | 2000-05-03 | |
| US60/201,516 | 2000-05-03 | ||
| PCT/US2000/013705 WO2000073445A2 (fr) | 1999-06-02 | 2000-05-17 | Promotion ou inhibition de l'angiogenese et de la cardiovascularisation |
| USPCT/US00/13705 | 2000-05-17 | ||
| PCT/US2000/014042 WO2000077037A2 (fr) | 1999-06-15 | 2000-05-22 | Polypeptides secretes et transmembranaires et acides nucleiques les codant |
| USPCT/US00/14042 | 2000-05-22 | ||
| USPCT/US00/14941 | 2000-05-30 | ||
| PCT/US2000/014941 WO2000073348A2 (fr) | 1999-06-02 | 2000-05-30 | Procedes et compositions visant a inhiber la proliferation des cellules cancereuses |
| USPCT/US00/15264 | 2000-06-02 | ||
| PCT/US2000/015264 WO2000073452A2 (fr) | 1999-06-02 | 2000-06-02 | Compositions et methodes de traitement de maladies liees a l'immunite |
| US20983200P | 2000-06-05 | 2000-06-05 | |
| US60/209,832 | 2000-06-05 | ||
| USPCT/US00/20710 | 2000-07-28 | ||
| PCT/US2000/020710 WO2001009327A2 (fr) | 1999-07-28 | 2000-07-28 | Procede de prevention de la deterioration ou de la mort des cellules de la retine et de traitement des troubles oculaires |
| US64484800A | 2000-08-22 | 2000-08-22 | |
| US09/644,848 | 2000-08-22 | ||
| PCT/US2000/023328 WO2001016318A2 (fr) | 1999-09-01 | 2000-08-24 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
| USPCT/US00/23328 | 2000-08-24 | ||
| US60/000,000 | 2000-09-15 | ||
| PCT/US2000/030952 WO2001049715A2 (fr) | 2000-01-06 | 2000-11-08 | Methodes et compositions permettant d'inhiber la croissance cellulaire neoplasique |
| USPCT/US00/30952 | 2000-11-08 | ||
| PCT/US2000/032678 WO2001040466A2 (fr) | 1999-12-01 | 2000-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides |
| USPCT/US00/32678 | 2000-12-01 | ||
| PCT/US2000/034956 WO2001046420A2 (fr) | 1999-12-23 | 2000-12-20 | Polypeptides homologues de l'il-17 et leurs utilisations therapeutiques |
| USPCT/US00/34956 | 2000-12-20 | ||
| CA002401448A CA2401448A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002401448A Division CA2401448A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2531917A1 true CA2531917A1 (fr) | 2001-09-20 |
Family
ID=40231083
Family Applications (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002401448A Abandoned CA2401448A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002534018A Abandoned CA2534018A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002531917A Abandoned CA2531917A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002533831A Abandoned CA2533831A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002539214A Abandoned CA2539214A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002534186A Abandoned CA2534186A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002534391A Abandoned CA2534391A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002533903A Abandoned CA2533903A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002533991A Abandoned CA2533991A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant lesdits polypeptides |
| CA002534030A Abandoned CA2534030A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002401448A Abandoned CA2401448A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002534018A Abandoned CA2534018A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
Family Applications After (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002533831A Abandoned CA2533831A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002539214A Abandoned CA2539214A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002534186A Abandoned CA2534186A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002534391A Abandoned CA2534391A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002533903A Abandoned CA2533903A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
| CA002533991A Abandoned CA2533991A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant lesdits polypeptides |
| CA002534030A Abandoned CA2534030A1 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1259614A2 (fr) |
| JP (3) | JP2004508805A (fr) |
| AU (2) | AU6802801A (fr) |
| CA (10) | CA2401448A1 (fr) |
| WO (1) | WO2001068848A2 (fr) |
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999009155A1 (fr) | 1997-08-19 | 1999-02-25 | Human Genome Sciences, Inc. | 70 proteines secretees humaines |
| US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| WO1999012963A2 (fr) | 1997-09-12 | 1999-03-18 | Biogen, Inc. | Recepteurs 'trail' riches en cysteine |
| US6849719B2 (en) | 1997-09-17 | 2005-02-01 | Human Genome Sciences, Inc. | Antibody to an IL-17 receptor like protein |
| ATE442385T1 (de) * | 1997-09-17 | 2009-09-15 | Human Genome Sciences Inc | Interleukin-17 rezeptor-ähnliches protein |
| US20030039648A1 (en) | 1998-09-16 | 2003-02-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20030130182A1 (en) * | 1997-11-05 | 2003-07-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
| AU740405B2 (en) | 1998-05-15 | 2001-11-01 | Genentech Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
| US6344541B1 (en) | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
| US20030190669A1 (en) | 1998-12-30 | 2003-10-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6291663B1 (en) * | 1999-03-03 | 2001-09-18 | Board Of Trustees Of The University Of Arkansas | TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma |
| US8133734B2 (en) | 1999-03-16 | 2012-03-13 | Human Genome Sciences, Inc. | Kit comprising an antibody to interleukin 17 receptor-like protein |
| EP1177295A1 (fr) * | 1999-05-13 | 2002-02-06 | Medical Research Council | Homologues de recepteur ox2 |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| EP1637541B1 (fr) * | 1999-09-01 | 2010-03-03 | Genentech, Inc. | Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci |
| EP1230349B1 (fr) | 1999-11-18 | 2007-06-13 | Dendreon Corporation | Acides nucleiques codant pour des endotheliases, endotheliases et leurs utilisations |
| US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| EP1897944B1 (fr) * | 1999-12-23 | 2011-08-10 | Genentech, Inc. | Polypeptides allogéniques IL-17 et utilisations thérapeutiques |
| WO2002000857A2 (fr) * | 2000-06-15 | 2002-01-03 | Millennium Pharmaceuticals, Inc. | Acyltransférase humaine 53320 nouvellement découverte et ses utilisations |
| WO2002026834A2 (fr) * | 2000-09-25 | 2002-04-04 | Millennium Pharmaceuticals Inc. | Element de la famille de udp-glucuronosyle et glycosyle transferase humaine, 32624, et utilisations correspondantes |
| US7094566B2 (en) | 2000-03-16 | 2006-08-22 | Amgen Inc., | IL-17 receptor like molecules and uses thereof |
| US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| EP1280923A2 (fr) | 2000-04-28 | 2003-02-05 | Millennium Pharmaceuticals, Inc. | 14094, un nouveau membre dans la famille de la trypsine humaine et son utilisation |
| US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20030031675A1 (en) | 2000-06-06 | 2003-02-13 | Mikesell Glen E. | B7-related nucleic acids and polypeptides useful for immunomodulation |
| WO2001094413A2 (fr) | 2000-06-06 | 2001-12-13 | Bristol-Myers Squibb Company | Acides nucleiques et polypeptides apparentes a b7 utiles pour effectuer une immunomodulation |
| AU2001270058B2 (en) * | 2000-06-22 | 2006-11-02 | Biogen Idec Ma Inc. | GP354 nucleic acids and polypeptides |
| MXPA02012749A (es) * | 2000-06-30 | 2003-10-06 | Amgen Inc | Moleculas semejantes a b7 y sus usos. |
| EP1307557A2 (fr) | 2000-08-02 | 2003-05-07 | The Johns Hopkins University | Profils d'expression de cellules endotheliales |
| AU2001229503A1 (en) * | 2000-08-28 | 2002-03-13 | Human Genome Sciences, Inc. | 17 human secreted proteins |
| WO2002020800A2 (fr) * | 2000-09-01 | 2002-03-14 | Millennium Pharmaceuticals, Inc. | Kinases 16658, 14223, et 16002, et utilisations |
| HUP0600776A2 (en) | 2000-11-14 | 2007-01-29 | Bristol Myers Squibb Co | A human serpin secreted from lymphoid cells lsi-01 |
| DE10106835A1 (de) * | 2001-02-14 | 2002-09-05 | Basf Lynx Bioscience Ag | Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen |
| WO2002064769A1 (fr) * | 2001-02-15 | 2002-08-22 | Shionogi & Co., Ltd. | Nouveau marqueur de maladies |
| EP1873245A1 (fr) * | 2001-02-28 | 2008-01-02 | Genentech, Inc. | Polypeptides homologue à l'interleukine-8 et utilisations thérapeutiques correspondantes |
| JP2004533222A (ja) * | 2001-03-12 | 2004-11-04 | インサイト・ゲノミックス・インコーポレイテッド | 免疫グロブリンスーパーファミリータンパク質 |
| AU2002305052A1 (en) | 2001-03-13 | 2002-09-24 | Corvas International, Inc. | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
| EP1383884A4 (fr) | 2001-03-22 | 2004-12-15 | Dendreon Corp | Molecules d'acide nucleique codant la serine protease cvsp14, polypeptides codes et procedes |
| NZ527971A (en) | 2001-03-27 | 2006-03-31 | Dendreon Corp | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
| EP2280030A3 (fr) | 2001-04-10 | 2011-06-15 | Agensys, Inc. | Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers |
| EP1421208A4 (fr) | 2001-04-11 | 2004-10-06 | Bristol Myers Squibb Co | Polynucleotides codant deux nouveaux recepteurs couples aux proteines g, hgprbmy28 et hgprbmy29, et leurs variants d'epissage |
| WO2002092841A2 (fr) | 2001-05-14 | 2002-11-21 | Dendreon San Diego Llc | Molecules d'acides nucleiques codant pour une serine protease transmembranaire 10, polypeptides codes et methodes associees |
| WO2005010044A2 (fr) | 2003-07-08 | 2005-02-03 | Genentech, Inc. | Polypeptides heterologues il-17 a/f et utilisation des polypeptides a des fins therapeutiques |
| US7125663B2 (en) | 2001-06-13 | 2006-10-24 | Millenium Pharmaceuticals, Inc. | Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer |
| WO2003000021A2 (fr) * | 2001-06-22 | 2003-01-03 | Biogen, Inc. | Acides nucleiques et polypeptides pancam |
| WO2003004530A1 (fr) * | 2001-07-06 | 2003-01-16 | Bayer Aktiengesellschaft | Régulation de la protéine semblable à un récepteur de la somatostatine humaine |
| CA2453653A1 (fr) * | 2001-07-26 | 2003-02-06 | Genset S.A. | Polynucleotides et polypeptides gmg-2 et leurs utilisations |
| JP4702819B2 (ja) | 2001-08-01 | 2011-06-15 | 生化学工業株式会社 | コンドロイチン合成酵素 |
| US7262026B2 (en) | 2001-08-23 | 2007-08-28 | Japan Science And Technology Agency | Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
| ES2431929T3 (es) * | 2001-09-18 | 2013-11-28 | Genentech, Inc. | Composiciones y procedimientos para el diagnóstico y el tratamiento de tumores |
| WO2003025162A2 (fr) * | 2001-09-20 | 2003-03-27 | Bayer Healthcare Ag | Regulation du precurseur de la sous-unite alpha de prolyl 4-hydroxylase humaine |
| WO2003039462A2 (fr) * | 2001-11-02 | 2003-05-15 | Tanox, Inc. | Antigene specifique du lymphome des lymphocytes b destine a etre utilise dans le diagnostic et le traitement des malignites des lymphocytes b |
| WO2003054164A2 (fr) | 2001-12-19 | 2003-07-03 | Immunex Corporation | Polypeptide de lectine de type c, polynucleotide et procedes de fabrication et d'utilisation correspondant |
| DE10211088A1 (de) * | 2002-03-13 | 2003-09-25 | Ugur Sahin | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| EP1494709A4 (fr) * | 2002-04-17 | 2006-06-28 | Genentech Inc | Compositions et procedes pour le diagnostic et le traitement de tumeurs |
| EP2275118A3 (fr) | 2002-05-29 | 2011-10-19 | DeveloGen Aktiengesellschaft | Proteines specifiques du pancreas |
| JPWO2003102182A1 (ja) * | 2002-05-31 | 2005-09-29 | 猪子 英俊 | 炎症性皮膚疾患に関連するｓｌｕｒｐ−２遺伝子およびその利用 |
| US7232676B2 (en) * | 2002-05-31 | 2007-06-19 | Seikagaku Kogyo Kabushiki Kaisha | Chondroitin synthase and nucleic acid encoding the enzyme |
| EP2305710A3 (fr) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Bibliothèques de phages et anticorps synthétiques |
| DE10242016A1 (de) * | 2002-09-11 | 2004-03-25 | Esplora GmbH c/o TU Darmstadt Institut für Biochemie | Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon |
| WO2004024077A2 (fr) * | 2002-09-11 | 2004-03-25 | Genentech, Inc. | Nouvelle composition et nouveaux procedes pour le traitement du psoriasis |
| DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| WO2004058817A1 (fr) * | 2002-12-26 | 2004-07-15 | Takeda Pharmaceutical Company Limited | Nouvelles proteines et leur utilisation |
| CA2511556A1 (fr) * | 2002-12-27 | 2004-07-29 | Applied Research Systems Ars Holding N.V. | Nouveaux polypeptides de type fibrilline |
| EP1588167A4 (fr) * | 2003-01-16 | 2006-08-09 | Univ Virginia | Proteines lysozymoides specifiques du sperme |
| US7312197B2 (en) | 2003-02-24 | 2007-12-25 | University Of Maryland, Baltimore | Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
| US20040185559A1 (en) | 2003-03-21 | 2004-09-23 | Isis Pharmaceuticals Inc. | Modulation of diacylglycerol acyltransferase 1 expression |
| US20050025763A1 (en) | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
| US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
| JP2007528721A (ja) | 2003-08-14 | 2007-10-18 | ダイアックス コーポレイション | エンドセリアーゼ−２リガンド |
| US7825235B2 (en) | 2003-08-18 | 2010-11-02 | Isis Pharmaceuticals, Inc. | Modulation of diacylglycerol acyltransferase 2 expression |
| JPWO2005061704A1 (ja) * | 2003-12-24 | 2007-07-12 | 武田薬品工業株式会社 | 癌の予防・治療剤 |
| DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| RU2007104022A (ru) | 2004-07-02 | 2008-08-10 | Дженентек, Инк. (Us) | Композиции для лечения неходжкинской лимфомы и способы их применения |
| WO2006017673A2 (fr) | 2004-08-03 | 2006-02-16 | Biogen Idec Ma Inc. | Influence du taj sur les fonctions neuronales |
| CA2574881C (fr) | 2004-08-04 | 2013-01-08 | Amgen Inc. | Anticorps contre dkk-1 |
| US7544659B2 (en) | 2004-08-13 | 2009-06-09 | Genentech, Inc. | Promotion of axonal regeneration |
| EP1863340A2 (fr) * | 2005-03-11 | 2007-12-12 | Genentech, Inc. | Disruptions geniques, compositions et methodes afferentes |
| EP1790664A1 (fr) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Anticorps monoclonaux contre claudin-18 pour le traitement du cancer |
| NZ568015A (en) | 2005-12-08 | 2012-03-30 | Medarex Inc | Human monoclonal antibodies to O8E |
| WO2007107774A2 (fr) * | 2006-03-22 | 2007-09-27 | Cartela R & D Ab | Nouvelles méthodes de diagnostic et de traitement |
| EP2082645A1 (fr) * | 2006-04-19 | 2009-07-29 | Genentech, Inc. | Nouvelle dislocation de gènes, compositions et procédés correspondants |
| EP2057177B1 (fr) | 2006-08-04 | 2012-11-21 | Isis Pharmaceuticals, Inc. | Compositions et leurs utilisations dirigées sur la diacylglycérol acyltransférase 1 |
| ES2625259T3 (es) | 2006-08-29 | 2017-07-19 | Oxford Biotherapeutics Ltd | Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón |
| US8058014B2 (en) | 2006-09-29 | 2011-11-15 | University Of Maryland, Baltimore | Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2 |
| CA2721713C (fr) | 2008-05-05 | 2019-07-09 | Novimmune Sa | Anticorps a reaction croisee anti-il-17a/il-17f et leurs procedes d'utilisation |
| JP2011523560A (ja) * | 2008-06-02 | 2011-08-18 | ダナ−ファーバー キャンサー インスティテュート インク． | Ｘｂｐ１ペプチド、ｃｄ１３８ペプチドおよびｃｓ１ペプチド |
| PT2403878T (pt) | 2009-03-05 | 2017-09-01 | Squibb & Sons Llc | Anticorpos completamente humanos específicos a cadm1 |
| EP2427203B1 (fr) | 2009-05-05 | 2018-10-17 | Novimmune S.A. | Anticorps anti-il-17f et leurs utilisation |
| WO2013167153A1 (fr) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Anticorps utiles dans le diagnostic du cancer |
| WO2013174404A1 (fr) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer |
| CA2888803A1 (fr) | 2012-11-05 | 2014-05-08 | Jooeun Bae | Xbp1, cd138 et cs1, compositions pharmaceutiques qui comprennent les peptides et procedes d'utilisation de tels peptides et compositions |
| CN105073776B (zh) | 2012-11-13 | 2019-04-12 | 拜恩科技股份公司 | 用于治疗表达紧密连接蛋白的癌症疾病的制剂 |
| WO2014127785A1 (fr) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer |
| WO2014146672A1 (fr) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer |
| PE20180800A1 (es) | 2015-07-10 | 2018-05-09 | Ionis Pharmaceuticals Inc | Moduladores de diaciglicerol aciltransferasa 2 (dgat2) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999063088A2 (fr) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Proteines membranaires et acides nucleiques codant ces proteines |
| DE19817948A1 (de) * | 1998-04-17 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Endometrium-Tumor |
| WO2000058473A2 (fr) * | 1999-03-31 | 2000-10-05 | Curagen Corporation | Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx» |
| AU3774300A (en) * | 1999-06-02 | 2000-12-18 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU1807401A (en) * | 1999-11-30 | 2001-06-12 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
| CA2399776A1 (fr) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Acides nucleiques et polypeptides |
| MXPA03001645A (es) * | 2000-08-24 | 2004-05-14 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
-
2000
- 2000-11-29 AU AU6802801A patent/AU6802801A/xx active Pending
-
2001
- 2001-02-28 EP EP01945919A patent/EP1259614A2/fr not_active Withdrawn
- 2001-02-28 CA CA002401448A patent/CA2401448A1/fr not_active Abandoned
- 2001-02-28 WO PCT/US2001/006520 patent/WO2001068848A2/fr not_active Ceased
- 2001-02-28 CA CA002534018A patent/CA2534018A1/fr not_active Abandoned
- 2001-02-28 CA CA002531917A patent/CA2531917A1/fr not_active Abandoned
- 2001-02-28 JP JP2001567332A patent/JP2004508805A/ja not_active Withdrawn
- 2001-02-28 CA CA002533831A patent/CA2533831A1/fr not_active Abandoned
- 2001-02-28 AU AU2001268028A patent/AU2001268028A1/en not_active Abandoned
- 2001-02-28 CA CA002539214A patent/CA2539214A1/fr not_active Abandoned
- 2001-02-28 CA CA002534186A patent/CA2534186A1/fr not_active Abandoned
- 2001-02-28 CA CA002534391A patent/CA2534391A1/fr not_active Abandoned
- 2001-02-28 CA CA002533903A patent/CA2533903A1/fr not_active Abandoned
- 2001-02-28 CA CA002533991A patent/CA2533991A1/fr not_active Abandoned
- 2001-02-28 CA CA002534030A patent/CA2534030A1/fr not_active Abandoned
-
2005
- 2005-08-15 JP JP2005264294A patent/JP2006081548A/ja not_active Withdrawn
-
2008
- 2008-06-12 JP JP2008153789A patent/JP2008301822A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008301822A (ja) | 2008-12-18 |
| JP2004508805A (ja) | 2004-03-25 |
| AU6802801A (en) | 2001-09-24 |
| JP2006081548A (ja) | 2006-03-30 |
| CA2534391A1 (fr) | 2001-09-20 |
| CA2534186A1 (fr) | 2001-09-20 |
| CA2534030A1 (fr) | 2001-09-20 |
| CA2533991A1 (fr) | 2001-09-20 |
| CA2533831A1 (fr) | 2001-09-20 |
| CA2533903A1 (fr) | 2001-09-20 |
| CA2539214A1 (fr) | 2001-09-20 |
| AU2001268028A1 (en) | 2001-09-24 |
| WO2001068848A3 (fr) | 2002-08-29 |
| EP1259614A2 (fr) | 2002-11-27 |
| CA2401448A1 (fr) | 2001-09-20 |
| CA2534018A1 (fr) | 2001-09-20 |
| WO2001068848A2 (fr) | 2001-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7189838B2 (en) | PRO9834 nucleic acids | |
| US7087421B2 (en) | Pro1278 polypeptides | |
| CA2533991A1 (fr) | Polypeptides secretes et transmembranaires et acides nucleiques codant lesdits polypeptides | |
| US20030017541A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| US7084255B2 (en) | PRO1278 polypeptides | |
| US20040023321A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| US20030104548A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| US20030104547A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| US20030104551A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |